PCSK9 and type 2 diabetes mellitus: One example is the use of PCSK9 SNPs to mimic the low-density lipoprotein cholesterol-lowering PCSK9 inhibitor drug, where genetic evidence showed an additional association with increased risk of type-2 diabetes [18].